title: [Injection therapy of the prostate in prostatic tuberculosis].
abstract: Oral therapy of prostatic tuberculosis so far has only been able to achieve conversion in one-fifth of the cases. Since 1970 we have practiced the transcutaneous injection of the prostate and have achieved conversion in all cases within a short time. Injection of 1 g Streptomycin and 0.1 g INH twice a week over a period of four to five weeks was carried out in 90 patients. Complications contraindicating the treatment was not seen. The transcutaneous injection treatment of the prostate is indicated in all patients where cavernous changes in the prostate have been demonstrated by urethrography.
mesh_terms: D004359:Drug Therapy, Combination; D006801:Humans; D007267:Injections / Q000379:methods; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D011469:Prostatic Diseases / Q000188:drug therapy*; D013307:Streptomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014389:Tuberculosis, Male Genital / Q000188:drug therapy*
chemical_list: D007538:Isoniazid; D013307:Streptomycin
vernacular_title: Die transcutane Prostata-Injektions-Therapie der Prostatatuberkulose